• Celebrate National Pharmacy Week – October 18-24

    RxStrategies is are honored to recognize pharmacists and pharmacy technicians as they provide quality care in hospitals, health centers, pharmacies and other healthcare settings. Thank you for your invaluable contributions.   Learn more about the week >>

  • Clinical Insights: October 13, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New Drug Shortage No new update. New Drug Recall and Safety Alerts No… Read more »

  • Clinical Insights: October 6, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Alkindi® Sprinkle (hydrocortisone) Oral Granules – New Orphan Drug Approval – September 29, 2020 – Eton Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing… Read more »

  • Clinical Insights: September 29, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval NucalaTM (mepolizumab) Injection – New Approved Indication – September 25, 2020 – GlaxoSmithKline plc (GSK) announced… Read more »

  • Clinical Insights: September 22, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New Drug Shortage September 21, 2020  Indinavir (CRIXIVAN) Capsules (Discontinuation) September 18, 2020 Finasteride… Read more »

  • Clinical Insights: September 15, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval GavretoTM (pralsetinib) Capsules – New Drug Approval – September 4, 2020 – Roche announced that the United States (US) Food and Drug Administration (FDA) has approved Gavreto™ (pralsetinib)… Read more »

  • Clinical Insights: September 8, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Onureg® (azacitidine) Tablets – New Drug Approval – September 1, 2020 – The Food and Drug Administration approved azacitidine tablets (Onureg®, Celgene Corporation) for continued treatment of patients… Read more »

  • Clinical Insights: September 1, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval  Winlevi® (clascoterone) Cream – New Drug Approval – August 27, 2020 – Cassiopea SpA announced that the United States Food and Drug Administration (FDA) approved Winlevi® (clascoterone cream… Read more »

  • Clinical Insights: August 25, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Kesimpta® (ofatumumab) Injection – New Drug Approval – August 20, 2020 – Novartis announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157)… Read more »

  • Clinical Insights: August 18, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval EnspryngTM (satralizumab-mwge) Injection – New Drug Approval – August 17, 2020 – The U.S. Food and Drug Administration has approved EnspryngTM (satralizumab-mwge) for the treatment of neuromyelitis optica… Read more »